Clinical Trial Update: To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis [Phase 2]

View source ↗

Summary

Zeria Pharmaceutical completed a Phase 2 clinical trial evaluating the efficacy and safety of Z-215 in erosive esophagitis. The study enrolled patients with ref…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Esophagitis
• Gastroesophageal Reflux Disease

Drugs mentioned

• Z-215

Snippet

Sponsor: Zeria Pharmaceutical | Conditions: Esophagitis, Reflux | Phase 2 | Status: COMPLETED